| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |